Lumos Diagnostics Holdings (LDX.AX) Earnings Analysis
Lumos Diagnostics Holdings (LDX.AX) next reports earnings on 2026-09-01. Trailing P/E -5.51.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LDX.AX next report earnings?
| Next earnings date | 2026-09-01 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.01B |
LDX.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -0.00884 AUD | n/a | n/a | n/a |
| 2025-08-28 | -0.0089 AUD | n/a | n/a | n/a |
| 2024-12-30 | -0.00739 AUD | n/a | n/a | n/a |
LDX.AX valuation and analyst view
| Trailing P/E | -5.51 |
|---|---|
| Trailing EPS | -0.0121 AUD |
| Price / book | 9.91 |
| Dividend yield | 0.00% |
| Market cap | 0.07B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Lumos Diagnostics Holdings (LDX.AX)'s next earnings date?
Lumos Diagnostics Holdings is next scheduled to report on 2026-09-01 and revenue estimate of 0.01B.
Did LDX.AX beat earnings last quarter?
Consensus estimate data was not available for LDX.AX's 2026-02-26 report.
What is LDX.AX's current P/E ratio and EPS?
LDX.AX trades at a trailing P/E of -5.51 on trailing EPS of -0.012102755153074666 AUD.
What do analysts rate LDX.AX?
LDX.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.